Longboard pharmaceuticals announces commencement of public offering of common stock

La jolla, calif.--(business wire)---- $lbph #epilepsy--longboard pharmaceuticals, inc. (nasdaq: lbph), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell $150 million of shares of its voting common stock. in connection with the proposed offering, longboard expects to grant the underwriters a 30-day option to purchas.
LBPH Ratings Summary
LBPH Quant Ranking